Vanderbilt University Cancer Center — Nashville, Tennessee

Vanderbilt University Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37212.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt University Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection.

Sponsors: AlloVir.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University Cancer Center?

Vanderbilt University Cancer Center has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University Cancer Center conducted?

Vanderbilt University Cancer Center has 1 clinical trials on record. Their work covers Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection.

Is Vanderbilt University Cancer Center accredited by Crixeo Health?

Vanderbilt University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.